Drug Type Antibody drug conjugate (ADC) |
Synonyms VLS 211 |
Target |
Mechanism DNA intercalators, ROR1 antagonists(Inactive tyrosine-protein kinase transmembrane receptor ROR1 antagonists), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization VelosBio, Inc.Startup |
Active Organization VelosBio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ewing Sarcoma | Preclinical | US | VelosBio, Inc.Startup | - |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Preclinical | US | VelosBio, Inc.Startup | - |